Drug discovery in neuroscience is very challenging but the need is greater than ever. Perhaps the most important factor for successfully developing an effective therapy, is the identification of human disease relevant drug targets. Our group aims to elucidate the pathophysiological basis of human neurological disorders from genetic molecular networks to complex neural systems using human genetics, human models and human tissue wherever possible.
Understanding the disease pathways in these conditions will allow development of better disease models, more effective drug screening assays and ultimately meaningful therapies.
Professor Caleb Webber, DPAG
Professor Simon Lovestone, Psychiatry
Associated Professor Gabriele De Luca, NDCN
Dr Sally Cowley, Dunn School of Pathology
Dr Christoph Patsch, Hoffman La Roche, Basel
Emma Mee Hayes